CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Equity Method Investee	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Equity Method Investee	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2021	$ 169,651		$ 6	$ 593,784		$ (7)	$ (424,132)
Beginning balance, Shares at Dec. 31, 2021			57,150,274
Issuance of common stock from RSU vesting			87,140
Issuance of common stock from option exercises	1			1
Issuance of common stock from option exercises, Shares			293
Issuance of common stock pursuant to employee stock purchase plan	439			439
Issuance of common stock pursuant to employee stock purchase plan, Shares			147,871
Stock-based compensation	4,051			4,051
Other comprehensive gain (loss)	7					7
Net income (loss)	92,105						92,105
Ending balance at Mar. 31, 2022	266,254		$ 6	598,275			(332,027)
Ending balance, Shares at Mar. 31, 2022			57,385,578
Beginning balance at Dec. 31, 2022	177,978		$ 6	607,513		(404)	(429,137)
Beginning balance, Shares at Dec. 31, 2022			57,483,910
Issuance of common stock from RSU vesting			194,525
Issuance of common stock pursuant to employee stock purchase plan	150			150
Issuance of common stock pursuant to employee stock purchase plan, Shares			116,332
Stock-based compensation	2,369	$ 24		2,369	$ 24
Other comprehensive gain (loss)	222					222
Net income (loss)	(28,844)						(28,844)
Ending balance at Mar. 31, 2023	$ 151,899		$ 6	$ 610,056		$ (182)	$ (457,981)
Ending balance, Shares at Mar. 31, 2023			57,794,767